| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Graft vs Host Disease | 5 | 2023 | 111 | 2.430 |
Why?
|
| Receptor, Notch1 | 11 | 2020 | 61 | 2.020 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2023 | 211 | 1.850 |
Why?
|
| Anemia, Aplastic | 3 | 2024 | 10 | 1.740 |
Why?
|
| Protein Kinase C-theta | 4 | 2023 | 16 | 1.680 |
Why?
|
| Cell Differentiation | 14 | 2024 | 1348 | 1.600 |
Why?
|
| Cell-Penetrating Peptides | 6 | 2021 | 28 | 1.580 |
Why?
|
| Polymers | 8 | 2024 | 323 | 1.270 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2019 | 37 | 1.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2023 | 641 | 1.150 |
Why?
|
| Signal Transduction | 18 | 2020 | 3033 | 1.140 |
Why?
|
| Colitis | 6 | 2025 | 77 | 0.970 |
Why?
|
| Receptors, Notch | 5 | 2020 | 103 | 0.930 |
Why?
|
| Mice | 26 | 2025 | 10827 | 0.890 |
Why?
|
| Disease Models, Animal | 12 | 2025 | 2180 | 0.890 |
Why?
|
| Th1 Cells | 3 | 2018 | 174 | 0.890 |
Why?
|
| Forkhead Transcription Factors | 3 | 2020 | 129 | 0.870 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2024 | 35 | 0.830 |
Why?
|
| Interleukin-12 | 1 | 2024 | 128 | 0.830 |
Why?
|
| Cell Plasticity | 1 | 2023 | 18 | 0.810 |
Why?
|
| Bone Marrow | 2 | 2015 | 181 | 0.810 |
Why?
|
| Interleukin-6 | 2 | 2023 | 321 | 0.760 |
Why?
|
| Lymphocyte Activation | 8 | 2020 | 760 | 0.730 |
Why?
|
| Animals | 35 | 2025 | 20634 | 0.730 |
Why?
|
| Amyloid Precursor Protein Secretases | 9 | 2020 | 77 | 0.710 |
Why?
|
| Antibodies | 3 | 2020 | 182 | 0.680 |
Why?
|
| Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2020 | 4 | 0.680 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein L | 1 | 2020 | 4 | 0.680 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 388 | 0.670 |
Why?
|
| Intracellular Fluid | 1 | 2020 | 32 | 0.670 |
Why?
|
| Carcinogenesis | 5 | 2025 | 130 | 0.660 |
Why?
|
| Adoptive Transfer | 1 | 2020 | 148 | 0.650 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 1617 | 0.650 |
Why?
|
| Immune Tolerance | 1 | 2020 | 176 | 0.630 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2019 | 62 | 0.610 |
Why?
|
| Transcription Factors | 4 | 2018 | 1514 | 0.600 |
Why?
|
| Rotenone | 1 | 2018 | 10 | 0.590 |
Why?
|
| Electron Transport Complex I | 1 | 2018 | 15 | 0.590 |
Why?
|
| Colonic Neoplasms | 4 | 2025 | 221 | 0.590 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2019 | 94 | 0.570 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 349 | 0.570 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 113 | 0.560 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 147 | 0.540 |
Why?
|
| Gene Expression | 3 | 2022 | 839 | 0.540 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 674 | 0.530 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2023 | 242 | 0.530 |
Why?
|
| Isoenzymes | 1 | 2016 | 139 | 0.510 |
Why?
|
| Protein Kinase C | 1 | 2016 | 102 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 16 | 2025 | 3391 | 0.490 |
Why?
|
| MicroRNAs | 2 | 2020 | 685 | 0.460 |
Why?
|
| Receptors, CXCR4 | 1 | 2015 | 36 | 0.460 |
Why?
|
| Guanidine | 5 | 2018 | 23 | 0.450 |
Why?
|
| Th17 Cells | 3 | 2023 | 61 | 0.450 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 233 | 0.440 |
Why?
|
| Cytokines | 7 | 2024 | 934 | 0.430 |
Why?
|
| Models, Immunological | 1 | 2012 | 85 | 0.380 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2012 | 7 | 0.380 |
Why?
|
| Interleukin-10 | 3 | 2025 | 160 | 0.360 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 101 | 0.360 |
Why?
|
| Interferon-gamma | 4 | 2020 | 566 | 0.350 |
Why?
|
| RNA, Small Interfering | 6 | 2019 | 922 | 0.350 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2012 | 287 | 0.340 |
Why?
|
| Proteins | 4 | 2018 | 751 | 0.340 |
Why?
|
| Enzyme Inhibitors | 3 | 2019 | 373 | 0.340 |
Why?
|
| Colon | 3 | 2022 | 146 | 0.320 |
Why?
|
| Eicosanoids | 2 | 2020 | 25 | 0.320 |
Why?
|
| Biocompatible Materials | 2 | 2024 | 150 | 0.320 |
Why?
|
| Humans | 34 | 2024 | 63283 | 0.290 |
Why?
|
| NF-kappa B | 4 | 2018 | 469 | 0.290 |
Why?
|
| Mice, Knockout | 7 | 2025 | 2107 | 0.290 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 525 | 0.290 |
Why?
|
| T-Lymphocytes | 3 | 2015 | 1007 | 0.280 |
Why?
|
| Immunomodulation | 2 | 2018 | 30 | 0.270 |
Why?
|
| Anti-Infective Agents | 2 | 2020 | 150 | 0.270 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 6 | 2021 | 264 | 0.260 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2020 | 86 | 0.250 |
Why?
|
| Protease Inhibitors | 2 | 2008 | 102 | 0.240 |
Why?
|
| Endopeptidases | 1 | 2005 | 67 | 0.230 |
Why?
|
| Apoptosis | 3 | 2019 | 1073 | 0.230 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2025 | 28 | 0.230 |
Why?
|
| Triclosan | 2 | 2022 | 9 | 0.230 |
Why?
|
| Drug Carriers | 2 | 2017 | 179 | 0.220 |
Why?
|
| Jurkat Cells | 7 | 2018 | 110 | 0.220 |
Why?
|
| Protein Binding | 5 | 2022 | 1602 | 0.220 |
Why?
|
| Bone Marrow Diseases | 1 | 2024 | 14 | 0.220 |
Why?
|
| Sirtuin 1 | 1 | 2024 | 26 | 0.210 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 663 | 0.210 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 1184 | 0.210 |
Why?
|
| HLA-A2 Antigen | 1 | 2023 | 64 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2002 | 304 | 0.200 |
Why?
|
| Transplantation, Homologous | 2 | 2023 | 243 | 0.200 |
Why?
|
| Presenilin-2 | 2 | 2020 | 20 | 0.200 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 429 | 0.200 |
Why?
|
| Protein Isoforms | 1 | 2023 | 197 | 0.190 |
Why?
|
| Thymus Gland | 1 | 2003 | 233 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 881 | 0.190 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2022 | 30 | 0.190 |
Why?
|
| Epithelium | 1 | 2002 | 96 | 0.190 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 2022 | 6 | 0.190 |
Why?
|
| Glucuronidase | 1 | 2022 | 24 | 0.190 |
Why?
|
| Carcinogens | 1 | 2022 | 37 | 0.190 |
Why?
|
| Mammary Glands, Animal | 1 | 2002 | 79 | 0.180 |
Why?
|
| Immunophenotyping | 2 | 2020 | 195 | 0.180 |
Why?
|
| CD28 Antigens | 2 | 2020 | 60 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 4 | 2020 | 676 | 0.180 |
Why?
|
| Protein Transport | 2 | 2021 | 401 | 0.170 |
Why?
|
| Norbornanes | 2 | 2017 | 7 | 0.170 |
Why?
|
| Linoleic Acid | 1 | 2020 | 19 | 0.170 |
Why?
|
| Jagged-1 Protein | 1 | 2020 | 8 | 0.170 |
Why?
|
| Carbanilides | 1 | 2020 | 3 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 341 | 0.170 |
Why?
|
| Protein Stability | 1 | 2020 | 92 | 0.160 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 326 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 59 | 0.160 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 92 | 0.160 |
Why?
|
| Macrophages | 3 | 2019 | 1038 | 0.160 |
Why?
|
| Mice, Transgenic | 5 | 2020 | 1276 | 0.160 |
Why?
|
| Gene Order | 1 | 2019 | 32 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 165 | 0.160 |
Why?
|
| Heterografts | 1 | 2019 | 63 | 0.150 |
Why?
|
| Cell Nucleus | 3 | 2012 | 626 | 0.150 |
Why?
|
| Presenilin-1 | 1 | 2019 | 61 | 0.150 |
Why?
|
| Female | 8 | 2020 | 32776 | 0.150 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2019 | 29 | 0.150 |
Why?
|
| Mice, SCID | 1 | 2020 | 520 | 0.150 |
Why?
|
| Neoplasms | 2 | 2020 | 1359 | 0.150 |
Why?
|
| Multiple Sclerosis | 2 | 2020 | 218 | 0.150 |
Why?
|
| HEK293 Cells | 5 | 2020 | 620 | 0.150 |
Why?
|
| Treatment Outcome | 2 | 2020 | 5647 | 0.150 |
Why?
|
| Metabolomics | 1 | 2019 | 53 | 0.150 |
Why?
|
| Organ Specificity | 1 | 2019 | 195 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 280 | 0.150 |
Why?
|
| Benzethonium | 1 | 2018 | 2 | 0.150 |
Why?
|
| Xylenes | 1 | 2018 | 4 | 0.150 |
Why?
|
| Benzalkonium Compounds | 1 | 2018 | 4 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2018 | 14 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2020 | 2152 | 0.150 |
Why?
|
| Intracellular Space | 1 | 2018 | 35 | 0.150 |
Why?
|
| Transduction, Genetic | 3 | 2016 | 237 | 0.140 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 99 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 176 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2018 | 94 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2019 | 985 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 429 | 0.140 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 321 | 0.130 |
Why?
|
| Monocytes | 1 | 2019 | 353 | 0.130 |
Why?
|
| Dextran Sulfate | 3 | 2025 | 40 | 0.130 |
Why?
|
| Cell Tracking | 1 | 2016 | 7 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 248 | 0.130 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 371 | 0.130 |
Why?
|
| Biomimetic Materials | 1 | 2016 | 37 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2022 | 766 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2016 | 937 | 0.120 |
Why?
|
| Cyclins | 2 | 2008 | 41 | 0.120 |
Why?
|
| Cytoplasm | 2 | 2018 | 276 | 0.120 |
Why?
|
| Molecular Mimicry | 1 | 2015 | 31 | 0.120 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 2020 | 59 | 0.120 |
Why?
|
| Amyloid beta-Peptides | 2 | 2020 | 297 | 0.120 |
Why?
|
| Mitochondria | 1 | 2018 | 371 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 879 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2025 | 236 | 0.110 |
Why?
|
| Dendritic Cells | 3 | 2023 | 524 | 0.100 |
Why?
|
| Peptides | 1 | 2017 | 574 | 0.100 |
Why?
|
| RNA Interference | 4 | 2020 | 618 | 0.100 |
Why?
|
| Genetic Vectors | 1 | 2019 | 872 | 0.100 |
Why?
|
| Biomarkers | 1 | 2018 | 1396 | 0.100 |
Why?
|
| Azoxymethane | 2 | 2025 | 17 | 0.100 |
Why?
|
| Dependovirus | 1 | 2019 | 709 | 0.100 |
Why?
|
| Plaque, Amyloid | 1 | 2012 | 40 | 0.100 |
Why?
|
| Male | 7 | 2020 | 29799 | 0.100 |
Why?
|
| Inflammation | 1 | 2018 | 1146 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1592 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2025 | 344 | 0.080 |
Why?
|
| Cell Survival | 2 | 2019 | 569 | 0.080 |
Why?
|
| T-Box Domain Proteins | 2 | 2009 | 38 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2008 | 10 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2008 | 16 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 49 | 0.070 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2009 | 148 | 0.070 |
Why?
|
| Biological Transport | 2 | 2021 | 291 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 60 | 0.070 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2018 | 20 | 0.070 |
Why?
|
| Immunotherapy | 2 | 2020 | 255 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2019 | 661 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2018 | 364 | 0.060 |
Why?
|
| Protein Domains | 2 | 2017 | 147 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 39 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 201 | 0.060 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2005 | 19 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2005 | 37 | 0.060 |
Why?
|
| Bacterial Translocation | 1 | 2025 | 11 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2005 | 203 | 0.060 |
Why?
|
| CD3 Complex | 2 | 2020 | 65 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2016 | 535 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 451 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 373 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2025 | 325 | 0.050 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2003 | 16 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2023 | 116 | 0.050 |
Why?
|
| Salmonella | 1 | 2023 | 44 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 136 | 0.050 |
Why?
|
| Gamma Rays | 1 | 2002 | 32 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 69 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 53 | 0.050 |
Why?
|
| Biotransformation | 1 | 2022 | 22 | 0.050 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2022 | 10 | 0.050 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2022 | 22 | 0.050 |
Why?
|
| Caspases | 1 | 2003 | 174 | 0.050 |
Why?
|
| Hormones | 1 | 2002 | 60 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2002 | 236 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 302 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2022 | 86 | 0.050 |
Why?
|
| Estrogens | 1 | 2002 | 116 | 0.050 |
Why?
|
| Progesterone | 1 | 2002 | 163 | 0.050 |
Why?
|
| Anticarcinogenic Agents | 1 | 2022 | 78 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 363 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 1199 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 449 | 0.040 |
Why?
|
| Lipocalin-2 | 1 | 2020 | 9 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 701 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 20 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 1465 | 0.040 |
Why?
|
| Proadifen | 1 | 2019 | 3 | 0.040 |
Why?
|
| Clotrimazole | 1 | 2019 | 9 | 0.040 |
Why?
|
| Binding Sites | 1 | 2022 | 903 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 74 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 721 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 205 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2019 | 144 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 416 | 0.040 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2019 | 144 | 0.040 |
Why?
|
| Avidin | 1 | 2018 | 11 | 0.040 |
Why?
|
| Streptavidin | 1 | 2018 | 32 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2018 | 7 | 0.040 |
Why?
|
| Consumer Product Safety | 1 | 2018 | 12 | 0.040 |
Why?
|
| Muramidase | 1 | 2018 | 46 | 0.040 |
Why?
|
| Cosmetics | 1 | 2018 | 17 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2019 | 335 | 0.040 |
Why?
|
| Metabolome | 1 | 2018 | 30 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2019 | 127 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 453 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 144 | 0.040 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2019 | 211 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2022 | 1148 | 0.040 |
Why?
|
| Methylmethacrylate | 1 | 2017 | 3 | 0.030 |
Why?
|
| Endocytosis | 1 | 2018 | 152 | 0.030 |
Why?
|
| Drug Liberation | 1 | 2017 | 21 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2019 | 237 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 158 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 49 | 0.030 |
Why?
|
| Integrases | 1 | 2017 | 37 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 198 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 459 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 860 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2017 | 246 | 0.030 |
Why?
|
| Liver | 1 | 2020 | 851 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 358 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 692 | 0.030 |
Why?
|
| Pregnancy | 1 | 2002 | 2330 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 453 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2017 | 778 | 0.030 |
Why?
|
| Methacrylates | 1 | 2014 | 38 | 0.030 |
Why?
|
| Child | 1 | 2023 | 4522 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 179 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 2014 | 160 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 2071 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2011 | 94 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 319 | 0.020 |
Why?
|
| Granzymes | 1 | 2009 | 21 | 0.020 |
Why?
|
| Perforin | 1 | 2009 | 31 | 0.020 |
Why?
|
| Receptor, Notch4 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Receptor, Notch2 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Receptor, Notch3 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 2008 | 24 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 37 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2008 | 51 | 0.020 |
Why?
|
| G1 Phase | 1 | 2008 | 56 | 0.020 |
Why?
|
| Azepines | 1 | 2008 | 21 | 0.020 |
Why?
|
| S Phase | 1 | 2008 | 77 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2008 | 22 | 0.020 |
Why?
|
| Alanine | 1 | 2008 | 51 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2009 | 181 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 291 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2008 | 117 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 325 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 746 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2005 | 27 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2005 | 16 | 0.020 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2005 | 24 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 524 | 0.020 |
Why?
|
| Base Sequence | 1 | 2008 | 1329 | 0.020 |
Why?
|
| Cytosol | 1 | 2005 | 179 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 483 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 2003 | 15 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2003 | 18 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 1555 | 0.010 |
Why?
|
| Lipid A | 1 | 2003 | 66 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2003 | 156 | 0.010 |
Why?
|
| Chemoprevention | 1 | 2002 | 41 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2002 | 72 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 614 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 625 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 718 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1539 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 3757 | 0.010 |
Why?
|